Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis

Not Applicable

Completed

• Conditions: Meningitis, Cryptococcal; HIV Infections

• Registration Number: NCT00002076
• Lead Sponsor: Pfizer

Brief Summary

To evaluate the safety and effectiveness of fluconazole as treatment for acute cryptococcal meningitis in AIDS patients. Both newly diagnosed and relapsed patients are eligible.

Detailed Description

Not available

Study Timeline

• Status Verified: 1990-02
• Study First Submitted: 1999-11-02
• Study First Submitted QC: 2001-08-30
• Study First Posted: 2001-08-31
• Last Update Submitted: 2005-06-23
• Last Update Posted: 2005-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (3)

Summitt Med Ctr / San Francisco Gen Hosp; 🇺🇸 Oakland, California, United States

Cornell Univ Med Ctr; 🇺🇸 New York, New York, United States

Buckley Braffman Stern Med Associates; 🇺🇸 Philadelphia, Pennsylvania, United States